問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberDU176b-C-U301

2009-02-15 - 2012-09-15

Phase III

Terminated16

  • Trial Applicant

    IQVIA RDS Taiwan Ltd.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hung-I Yeh Division of Cardiovascular Diseases

Co-Principal Investigator

  • 陳俊延 Division of Cardiovascular Diseases
  • 洪大川 Division of Cardiovascular Diseases
  • 郭任遠 Division of Cardiovascular Diseases
  • 李應湘 Division of Cardiovascular Diseases
  • 蘇正煌 Division of Cardiovascular Diseases
  • 吳懿哲 Division of Cardiovascular Diseases
  • 林慧君 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 夏建勳 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 陳雅珮 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 王志鴻 Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator JIN–LONG HUANG Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Chi-Tai Kuo Division of Cardiovascular Diseases

Co-Principal Investigator

  • 王俊力 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator WEN-TER Lai Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 韓志陸 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 李俊泰 Division of Cardiovascular Diseases
  • 鄭正忠 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 鄭成泉 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 吳文憲 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 邱春旺 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 葉同成 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 曾維功 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 宣錦峰 Division of Cardiovascular Diseases
  • 潘亞峰 Division of Cardiovascular Diseases
  • 李統立 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 江福田 Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Pei-Ying Pai Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 徐國基 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 邱俊仁 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 翁國昌 Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hung-I Yeh Division of Cardiovascular Diseases

Co-Principal Investigator

  • 陳俊延 Division of Cardiovascular Diseases
  • 洪大川 Division of Cardiovascular Diseases
  • 郭任遠 Division of Cardiovascular Diseases
  • 李應湘 Division of Cardiovascular Diseases
  • 蘇正煌 Division of Cardiovascular Diseases
  • 吳懿哲 Division of Cardiovascular Diseases
  • 林慧君 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    240 participants

  • Global

    16500 participants